Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability of N-chlorotaurine in infectious colpitis
2004-002416-29Phase 2Terminated
- Sponsor
- Section for Hygiene and Medical Microbiology, Medical University of Innsbruck
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of N-chlorotaurine in vaginitis, bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC), sponsored by Section for Hygiene and Medical Microbiology, Medical University of Innsbruck. Primary endpoint: Symptoms after 7 to 10 days of treatment. Started Nov 2004; status: terminated.
02
Drugs
N-chlorotaurine
03
Conditions
vaginitisbacterial vaginosis (BV)vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on 2004-002416-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002416-29.